artículo
Light-induced release of the cardioprotective peptide angiotensin-(1-9) from thermosensitive liposomes with gold nanoclusters
Fecha
2020Registro en:
10.1016/j.jconrel.2020.11.002
1873-4995
0168-3659
MEDLINE:33160006
SCOPUS_ID:85182725436
WOS:000600791600062
Autor
Bejarano, Julian
Rojas, Aldo
Ramirez Sagredo, Andrea
Riveros, Ana L.
Morales Zavala, Francisco
Flores, Yvo
Riquelme, Jaime A.
Guzman, Fanny
Araya, Eyleen
Chiong, Mario
Ocaranza, María Paz
Morales, Javier O.
Villamizar Sarmiento, Maria Gabriela
Sanchez, Gina
Lavandero, Sergio
Kogan, Marcelo J.
Institución
Resumen
Angiotensin-(1-9), a component of the non-canonical renin-angiotensin system, has a short half-life in blood. This peptide has shown to prevent and/or attenuate hypertension and cardiovascular remodeling. A controlled release of angiotensin-(1-9) is needed for its delivery to the heart. Our aim was to develop a drug delivery system for angiotensin-(1-9). Thermosensitive liposomes (LipoTherm) were prepared with gold nanoclusters (LipoThermAuNC) to increase the stability and reach a temporal and spatial control of angiotensin-(1-9) release. Encapsulation efficiencies of nearly 50% were achieved in LipoTherm, reaching a total angiotensin-(1-9) loading of around 180 mu M. This angiotensin-(1-9)-loaded LipoTherm sized around 100 nm and exhibited a phase transition temperature of 43.C. AuNC were grown on LipoTherm and the new hybrid nanosystem showed energy absorption in the near-infrared (NIR) wavelength range. By NIR laser irradiation, a controlled release of angiotensin-(1-9) was achieved from the LipoTherm-AuNC nanosystem. These nanosystems did not show any cytotoxic effect on cultured cardiomyocytes. Biological activity of angiotensin-(1-9) released from the LipoTherm-AuNCbased nanosystem was confirmed using an ex vivo Langendorff heart model.